Well Bioprints
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Well Bioprints
Ronald Terrazas Mallea
Chief Technology Officer
About Well Bioprints
Well Bioprints provides B2B drug screening products and services based on advanced 3D cell models generated using our proprietary microfluidic technology. We offer high-throughput combinatorial toxicity screens which provide tens of combinations of different tissue models at hundreds of repetitions in a single screen. Our technology warrants high accuracy of results and reduces your reagent consumption by even orders of magnitude, while also limiting manual labor and eliminating tittering errors. Well Bioprints will bring the efficiency of your preclinical drug development to a new level.
Well Bioprints revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Well Bioprints has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Well Bioprints has never raised funding before.
Spain
Canada
United Kingdom
United States
FranceFrequently asked questions
4.8
40,000 users
